Free Trial

Praxis Investment Management Inc. Has $2.32 Million Position in CVS Health Corporation (NYSE:CVS)

CVS Health logo with Medical background

Praxis Investment Management Inc. boosted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 32.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,194 shares of the pharmacy operator's stock after purchasing an additional 8,340 shares during the quarter. Praxis Investment Management Inc.'s holdings in CVS Health were worth $2,317,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of CVS. Hopwood Financial Services Inc. acquired a new stake in CVS Health in the 4th quarter valued at $29,000. McIlrath & Eck LLC grew its position in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the period. Compass Planning Associates Inc acquired a new stake in CVS Health in the 4th quarter valued at $37,000. Providence First Trust Co acquired a new stake in CVS Health in the 4th quarter valued at $42,000. Finally, Park Square Financial Group LLC acquired a new stake in CVS Health in the 4th quarter valued at $43,000. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Trading Down 0.2%

NYSE CVS opened at $66.69 on Friday. The stock has a market capitalization of $84.36 billion, a price-to-earnings ratio of 15.92, a PEG ratio of 0.96 and a beta of 0.56. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The business's fifty day moving average is $64.92 and its 200-day moving average is $60.40.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period in the previous year, the business posted $1.31 EPS. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CVS. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, May 5th. UBS Group lifted their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price objective (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $74.75.

View Our Latest Stock Analysis on CVS

Insider Activity at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is currently owned by company insiders.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines